Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Targeted Oncology|July 14, 2019
Sunitinib for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis of Real-World and Clinical Trials DataMichael Moran, Dana Nickens, Katherine Adcock, et al.
Plastic and Reconstructive Surgery. Global Open|August 24, 2017
Vismodegib for Locally Advanced Periocular and Orbital Basal Cell Carcinoma: A Review of 15 Consecutive CasesKai Yuen Wong, Kate Fife, John T Lear, et al.
Future Oncology (London, England)|September 20, 2016
Managing adverse events associated with vismodegib in the treatment of basal cell carcinomaKate Fife, Robert Herd, Susan Lalondrelle, et al.
BMC Cancer|July 19, 2020
Treatment patterns and health outcomes in metastatic renal cell carcinoma patients treated with targeted systemic therapies in the UKRobert Hawkins, Kate Fife, Michael Hurst, et al.
Clinical Genitourinary Cancer|November 22, 2021
Early Clinical Experience with Cabozantinib for Advanced Renal Cell Carcinoma in the UK: Real-World Treatment Pathways and Clinical OutcomesBalaji Venugopal, Manon Pillai, Thomas Powles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2014
Modafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trialAnna Spathis, Kate Fife, Fiona Blackhall, et al.
World Journal of Urology|December 20, 2017
Prognostic effect of cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma: a comparative study using inverse probability of treatment weightingTobias Klatte, Kate Fife, Sarah J Welsh, et al.
Cancer Treatment Reviews|September 27, 2025
Impact of brain metastases on systemic renal cell carcinoma treatment outcomes: A systematic literature reviewNatalie Charnley, Kate Fife, Daniel Y C Heng, et al.
European Urology Focus|September 19, 2019
A Decision Analysis Evaluating Screening for Kidney Cancer Using Focused Renal UltrasoundSabrina H Rossi, Tobias Klatte, Juliet A Usher-Smith, et al.
The Oncologist|August 12, 2016
Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell CarcinomaMario E Lacouture, Brigitte Dréno, Paolo Antonio Ascierto, et al.
Pageof 4